Cancer treatment using electrical pulses and chemotherapy agent

Phase 1

• Conditions: Condition 1: Patients with stage 4 sarcoma cancer. Condition 2: Patients with stage 4 Squamous cell carcinoma cancer.; Kaposi's sarcoma of skin; Squamous cell carcinoma of skin of scalp and neck; C46.0; C44.42

• Registration Number: IRCT20230403057807N1
• Lead Sponsor: Bagheiat-allah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1- The patient has an accessible tumor (preferably SCC sarcoma).
2- the patient is not responding to standard treatments.
3- the patient does not have comorbidity diseases such as metal chips, platinum, and other metals in the scope of treatment.
4-2 oncologists consider this type of treatment necessary for the patient.

Exclusion Criteria

The patient have metal chips, platinum and other metals near the condition of treatment.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tumor volume. Timepoint: Before treatment, one month, three and six months after treatment. Method of measurement: MRI imaging.;Life quality. Timepoint: before and after treatment. Method of measurement: EORTC QLQ-C30 questionnaire (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire).